Receptor Heteromerization Expands the Repertoire of Cannabinoid Signaling in Rodent Neurons

A fundamental question in G protein coupled receptor biology is how a single ligand acting at a specific receptor is able to induce a range of signaling that results in a variety of physiological responses. We focused on Type 1 cannabinoid receptor (CB(1)R) as a model GPCR involved in a variety of processes spanning from analgesia and euphoria to neuronal development, survival and differentiation. We examined receptor dimerization as a possible mechanism underlying expanded signaling responses by a single ligand and focused on interactions between CB(1)R and delta opioid receptor (DOR). Using co-immunoprecipitation assays as well as analysis of changes in receptor subcellular localization upon co-expression, we show that CB(1)R and DOR form receptor heteromers. We find that heteromerization affects receptor signaling since the potency of the CB(1)R ligand to stimulate G-protein activity is increased in the absence of DOR, suggesting that the decrease in CB(1)R activity in the presence of DOR could, at least in part, be due to heteromerization. We also find that the decrease in activity is associated with enhanced PLC-dependent recruitment of arrestin3 to the CB(1)R-DOR complex, suggesting that interaction with DOR enhances arrestin-mediated CB(1)R desensitization. Additionally, presence of DOR facilitates signaling via a new CB(1)R-mediated anti-apoptotic pathway leading to enhanced neuronal survival. Taken together, these results support a role for CB(1)R-DOR heteromerization in diversification of endocannabinoid signaling and highlight the importance of heteromer-directed signal trafficking in enhancing the repertoire of GPCR signaling.